Loading...
XSTOALIF B
Market cap13bUSD
Dec 20, Last price  
136.80
1D
2.63%
1Q
-14.66%
Jan 2017
317.34%
IPO
475.90%
Name

AddLife AB

Chart & Performance

D1W1MN
XSTO:ALIF B chart
P/E
—
P/S
—
EPS
1.62
Div Yield, %
0.91%
Shrs. gr., 5y
3.90%
Rev. gr., 5y
31.30%
Revenues
9.69b
+6.62%
906,500,000983,500,0001,722,600,0001,562,400,0001,938,300,0002,333,300,0002,481,600,0003,479,400,0005,273,300,0007,992,600,0009,084,000,0009,685,000,000
Net income
190m
-60.42%
73,800,00078,000,000102,000,00077,800,000111,800,000120,300,000129,300,000140,600,000517,800,000719,000,000480,000,000190,000,000
CFO
773m
-14.96%
118,600,00091,600,000120,400,000117,700,000132,900,000208,000,000177,500,000400,400,000950,100,0001,010,200,000909,000,000773,000,000
Dividend
May 15, 20240.5 /sh
Earnings
Feb 05, 2025

Profile

AddLife AB (publ), together with its subsidiaries, provides equipment, medical devices, and reagents primarily to healthcare system, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for haematology, pathology, point-of-care diagnostics, cell biology, genetics, microbiology, virology, molecular biology, clinical chemistry, immunology, consumables, and analytical instruments segments. This segment also offers support, maintenance, advice, and training services. The Medtech segment provides medical device products for surgery, respiration, intensive care, wound care, enteral nutrition, fall prevention, welfare technology, ear, and nose and throat segments, as well as bathroom-related assistive devices and assistive devices for children with disabilities. It operates in Sweden, Finland, Denmark, Norway, the United Kingdom, Ireland, Germany, Italy, Austria, Switzerland, rest of Europe, and internationally. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden.
URL
https://www.add.life/
IPO date
Mar 16, 2015
Employees
2,296
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122016‑032015‑03
Income
Revenues
9,685,000
6.62%
9,084,000
13.66%
7,992,600
51.57%
Cost of revenue
9,319,000
8,405,000
7,043,100
Unusual Expense (Income)
NOPBT
366,000
679,000
949,500
NOPBT Margin
3.78%
7.47%
11.88%
Operating Taxes
147,000
119,000
206,600
Tax Rate
40.16%
17.53%
21.76%
NOPAT
219,000
560,000
742,900
Net income
190,000
-60.42%
480,000
-33.24%
719,000
38.86%
Dividends
(146,000)
(243,000)
(183,000)
Dividend yield
Proceeds from repurchase of equity
(9,000)
(27,000)
2,633,300
BB yield
Debt
Debt current
2,403,000
2,622,000
3,314,300
Long-term debt
3,390,000
3,325,000
1,132,400
Deferred revenue
113,400
Other long-term liabilities
179,000
202,000
2,100
Net debt
5,512,000
5,467,000
4,079,100
Cash flow
Cash from operating activities
773,000
909,000
1,010,200
CAPEX
(226,000)
(282,000)
(143,900)
Cash from investing activities
(317,000)
(1,086,000)
(2,977,900)
Cash from financing activities
(554,000)
134,000
2,070,900
FCF
(33,000)
(266,900)
23,000
Balance
Cash
272,000
376,000
345,300
Long term investments
9,000
104,000
22,300
Excess cash
25,800
Stockholders' equity
2,318,000
2,329,000
1,637,000
Invested Capital
10,428,000
10,668,200
8,399,000
ROIC
2.08%
5.87%
13.36%
ROCE
3.38%
6.09%
10.68%
EV
Common stock shares outstanding
121,861
122,254
119,966
Price
Market cap
EV
EBITDA
1,285,000
1,402,000
1,427,900
EV/EBITDA
Interest
288,000
112,000
56,900
Interest/NOPBT
78.69%
16.49%
5.99%